Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13

@inproceedings{Davis2017AvailabilityOE,
  title={Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13},
  author={Courtney Davis and Huseyin Naci and Evrim Gurpinar and Elita Poplavska and Ashlyn Pinto and Ajay Aggarwal},
  booktitle={BMJ},
  year={2017}
}
Objective To determine the availability of data on overall survival and quality of life benefits of cancer drugs approved in Europe.Design Retrospective cohort study.Setting Publicly accessible regulatory and scientific reports on cancer approvals by the European Medicines Agency (EMA) from 2009 to 2013.Main outcome measures Pivotal and postmarketing trials of cancer drugs according to their design features (randomisation, crossover, blinding), comparators, and endpoints. Availability and… CONTINUE READING

Tables and Topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
SHOWING 1-10 OF 53 CITATIONS, ESTIMATED 36% COVERAGE

EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties

  • Applied health economics and health policy
  • 2018
VIEW 5 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Postponement of Death by Statin Use: a Systematic Review and Meta-analysis of Randomized Clinical Trials

Morten Rix Hansen, Asbjørn Hróbjartsson, +7 authors Jesper Hallas
  • Journal of General Internal Medicine
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

FILTER CITATIONS BY YEAR

2017
2019

CITATION STATISTICS

  • 2 Highly Influenced Citations

  • Averaged 21 Citations per year over the last 3 years

  • 76% Increase in citations per year in 2018 over 2017

References

Publications referenced by this paper.
SHOWING 1-10 OF 70 REFERENCES

Early market access of cancer drugs in the EU.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2016

Similar Papers

Loading similar papers…